The combined treatment of MC38 mouse colon cancer with methotrexate nanocouplings and dendritic cells with down-regulated IL-10R expression has been shown to modulate the tumor microenvironment and enhance the systemic anti-tumor immune response (79). The gene discussed is IL10RA; the disease is neoplasm.